Healthcare

Self-screening kits that have been adopted in British Columbia won’t be a part of the upcoming rollout in Ontario, which means patients still need to visit the doctor to get tested.

Get the info you need on this new dosage forms, part of our drug news roundup for February.

Glucagon-like peptide-1 receptor agonists have gone Hollywood.

But most not getting psychotherapy or alternatives to medication.

A population-based study in the U.K. suggests that people with attention deficit disorder, with or without hyperactivity, die earlier than others.

Promised in 2023, the act would allow a family member, doctor or police officer to request a mandatory treatment order from a judge if someone is deemed a danger to themselves or others.

Robust guidelines from the American Society of Regional Anesthesia and Pain Medicine offer detailed recommendations to better prevent surgical site infections and, if needed, to treat them.

Get the info you need on this new product, part of our drug news roundup for February.